Navigation Links
Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
Date:11/2/2012

pies, and to evaluate the effects of the combination therapies on TG and other lipids and lipoproteins.

About Epanova™Epanova is a patent protected, novel, ultra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omthera has developed a substantial body of data on Epanova, which points to an improved and more predictable bioavailability as compared to the ethyl ester form found in prescription Omega-3 products currently available. Triglyceride lowering with Epanova was previously observed in two large, placebo-controlled, randomized, double-blind, Phase III studies involving 748 Crohn's disease patients with normal triglyceride levels for >/= 52 weeks, approximately 400 of which were treated with Epanova for remission of disease. In all studies performed to date, Epanova has demonstrated a very good safety and tolerability profile.

About HypertriglyceridemiaHypertriglyceridemia refers to a condition in which patients have high blood levels of triglycerides and is associated with increased risk of heart disease. It is one component of a range of lipid disorders collectively referred to as dyslipidemia. The overall dyslipidemia population in the U.S. is believed to be in excess of 100 million, with approximately 40 million of those diagnosed with hypertriglyceridemia (triglycerides greater than 200mg/dL) and an estimated 4 million with very high triglyceride levels (triglycerides greater than 500mg/dL). Very high triglycerides are associated with an increased risk of pancreatitis. Regulatory approval for the treatment of very high triglycerides is based on a significant reduction in the serum triglyceride levels.

About Omthera Pharmaceuticals, Inc.Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately held, specialty pharmaceutical company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... YORK , June 3, 2015 Trauma is ... as dislocation, fractures, or burns that are caused due to ... device is one of the most vital treatment methods adopted ... growth of the North America internal ... increasing adoption of supporting technologies. The North America ...
(Date:6/3/2015)... NEW YORK , June 3, 2015 The ... a CAGR of 8.3% from 2014 to 2019. In 2014, ... around 28.4% of the Asian pharmacy information systems market, followed ... a high potential for growth in future due to a ... venture capitalist investments, technological advancements, and increase number of healthcare ...
(Date:6/3/2015)... DIEGO , June 3, 2015  Diomics today ... clandestine service senior official, has joined the company,s board ... of the Intelligence Studies Project and Clinical Professor at ... the University of Texas at Austin. ... from having served 28 years as a member of ...
Breaking Medicine Technology:North America Internal Trauma Fixation Device Market, by Product Type, by End-User - Analysis & Forecasts to 2019 2Asia Pharmacy Information Systems Market By Type, By Component, By Deployment, By End-User - Analysis & Forecast To 2019 2Asia Pharmacy Information Systems Market By Type, By Component, By Deployment, By End-User - Analysis & Forecast To 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2
... June 3, 2011 CVS Caremark announced today that ... donations to support residents of Joplin, MO, including some ... their members, who were impacted by the recent tornado. ... and donated first aid and personal care supplies valued ...
... the 2011 SNM Annual Meeting in San Antonio, Siemens ... molecular imaging procedures and Siemens, efforts to expand molecular ... and new clinical applications. Through this benchmark-redefining growth of ... is "Expanding Your Return on Innovation." ...
Cached Medicine Technology:CVS Caremark and Area Colleagues Provide $40,000 of Support to Tornado Relief Efforts in Joplin, MO 2Siemens Expands Customer Return on Innovation at SNM 2011 2Siemens Expands Customer Return on Innovation at SNM 2011 3Siemens Expands Customer Return on Innovation at SNM 2011 4
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, ... of Mother’s Home to Gas Wells , PITTSBURGH, June 3, ... of natural gas wells drilled with hydraulic fracturing were more ... living farther from such wells, according to a University ... southwestern Pennsylvania birth records. , The finding does not ...
(Date:6/3/2015)... The Canton Group, a leading web and software ... that Tim Dodge has joined the company as Chief ... Group as it implements an ambitious growth strategy ... is a tech industry veteran who has developed and ... Before joining The Canton Group, Tim was Vice President ...
(Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
(Date:6/3/2015)... June 03, 2015 Alberto Grignolo, PhD, ... DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program ... of excellence, and commitment to service on a global ... Connector Award that annually recognizes one DIA member for ... the mission of DIA to foster innovation to improve ...
(Date:6/3/2015)... Z-Medica®, LLC, a leading developer and ... been designated as National Safety Month by the National ... Department for its commitment to public safety. , ... First Aid Kits (IFAK) over 100 times in the ... or traffic accidents. Each kit is equipped with what’s ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2
... The 2009 Cumulative Supplement to ... legal developments in pharmaceutical patent law. Published by ... , Pharmaceutical Patent Law is supplemented annually ... implications of patent settlements; the experimental use privilege; and international ...
... after the nation,s largest financing source for fertility treatments shut down its ... today announced a new loan program for women ... Home National Bank, the program can finance up to half the cost ... an in vitro fertilization (IVF) procedure using fresh ...
... SAN ANTONIO, Oct. 14 Inc. magazine ranked ... its 28th annual Inc. 500, an exclusive ranking of the ... look at the most important segment of the economy--America,s independent-minded ... going to change the world, look at the Inc. 500," ...
... onerous, futile medical interventions are ordered for these end-stage ... -- Many people see end-stage dementia as affecting only ... disease,s effects are far-reaching and eventually fatal. , ... not a terminal condition can have negative ...
... Finding may help tailor treatments to keep patients from ... News) -- U.S. researchers have identified a common gene ... statin drugs. , Statins can reduce high cholesterol and ... 25 percent to 50 percent of people prescribed the ...
... , Using small molecules (purine analogs) ... in lung cancer, a common obstacle to successful, ... /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com (HTDS) - The ... brings attention to its Mindup Bioresearch cancer project ...
Cached Medicine News:Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 2Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 3Health News:New Fertility Financing Program for Donated Eggs Fills Void Left by Capital One 2Health News:Inc. Magazine Unveils 28th Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Families Need to Know When Dementia Becomes Terminal 2Health News:Families Need to Know When Dementia Becomes Terminal 3Health News:Side Effects in Statin Users Linked to Gene Mutation 2Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 2Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 3Health News:Slavica Bio Chem MindUp Cancer Project (HTDS) Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: